{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:19:54Z","timestamp":1774581594660,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>We analysed the efficacy and safety of thrombolytic therapy with urokinase in patients with prosthetic valve thrombosis.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Twenty-three patients with valve thrombosis received thrombolytic treatment using urokinase. First, a 250,000\u2009IU intravenous bolus injection was administered as a loading dose, followed by intravenous infusion of 100,000\u2009IU\/h for 10\u2009h and anticoagulation with low molecular weight heparin every day. The maximum treatment time was 5\u00a0days, i.e., until the transvalvular pressure gradient was normal or close to normal. Transthoracic echocardiography (TTE) was used every 12\u2009h to monitor whether the thrombus was reduced and whether there was haemodynamic improvement. Routine blood tests, the prothrombin time (PT), international normalized ratio (INR) and complications were observed every day.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Sixteen (69.6%) patients were successfully treated with thrombolytic therapy: 2\/2 (100%) aortic valves and 14\/21 (66.7%) mitral valves. The partial success rate of this study was 13.0% (3\/23). Four patients did not show any improvement in haemodynamics. Two cases had slight urine haemorrhage. One patient died of severe cerebral haemorrhage and shock. The overall mortality was 13.0% (3\/23), including two patients who died after subsequent surgery.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Urokinase is more convenient and successful in the treatment of PVT. More experience may make TT the optimal treatment for PVT, especially in high-risk surgical situations.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13019-020-01324-7","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T05:44:12Z","timestamp":1601531052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Thrombolytic treatment of prosthetic valve thrombosis: a study using Urokinase"],"prefix":"10.1186","volume":"15","author":[{"given":"Feng","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongrong","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangbo","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6038-2598","authenticated-orcid":false,"given":"Fei","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"1324_CR1","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.jcmg.2012.10.016","volume":"6","author":"M Ozkan","year":"2013","unstructured":"Ozkan M, Gunduz S, Biteker M, et al. Comparison of different TEE-guided thrombolytic regimens for prosthetic valve thrombosis: the TROIA trial. JACC Cardiovasc Imaging. 2013;6:206\u201316.","journal-title":"JACC Cardiovasc Imaging"},{"key":"1324_CR2","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/eurheartj\/ehs486","volume":"21","author":"G Karthikeyan","year":"2013","unstructured":"Karthikeyan G, Senguttuvan NB, Joseph J, et al. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J. 2013;21:1557\u201366.","journal-title":"Eur Heart J"},{"key":"1324_CR3","first-page":"533","volume":"17","author":"M Laurent","year":"2008","unstructured":"Laurent M, Lelong B, Verhoye JP, et al. Prolonged heparin and vitamin K antagonist regimen for early non-obstructive thrombosis of mechanical mitral valve prostheses. J Heart Valve Dis. 2008;17:533\u201341.","journal-title":"J Heart Valve Dis"},{"key":"1324_CR4","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.1097\/MJT.0000000000000117","volume":"23","author":"J Garg","year":"2016","unstructured":"Garg J, Palaniswamy C, Pinnamaneni S, et al. Prosthetic valve thrombosis: diagnosis and management. Am J Ther. 2016;23:e252\u20135.","journal-title":"Am J Ther"},{"key":"1324_CR5","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1016\/j.hlc.2014.04.257","volume":"23","author":"C Sousa","year":"2014","unstructured":"Sousa C, Almeida J, Dias P, et al. Conservative management of a prosthetic valve thrombosis -report of a successful case. Heart Lung Circ. 2014;23:e207\u20139.","journal-title":"Heart Lung Circ"},{"key":"1324_CR6","first-page":"167","volume":"8","author":"M Lengyel","year":"1999","unstructured":"Lengyel M, Vegh G, Vandor L. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis. J Heart Valve Dis. 1999;8:167\u201373.","journal-title":"J Heart Valve Dis"},{"key":"1324_CR7","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/eurheartj\/ehs486","volume":"34","author":"G Karthikeyan","year":"2013","unstructured":"Karthikeyan G, Senguttuvan NB, Joseph J, et al. Urgent surgery compared with fibrinolytic therapy for the treatment of left-sided prosthetic heart valve thrombosis: a systematic review and meta-analysis of observational studies. Eur Heart J. 2013;34:1557\u201366.","journal-title":"Eur Heart J"},{"key":"1324_CR8","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1080\/17434440.2020.1733972","volume":"17","author":"S G\u00fcnd\u00fcz","year":"2020","unstructured":"G\u00fcnd\u00fcz S, Kal\u00e7\u0131k M, G\u00fcrsoy MO, et al. Diagnosis, treatment & management of prosthetic valve thrombosis: the key considerations. Expert Rev Med Devices. 2020;17:209\u201321.","journal-title":"Expert Rev Med Devices"},{"key":"1324_CR9","doi-asserted-by":"publisher","first-page":"e576S","DOI":"10.1378\/chest.11-2305","volume":"141","author":"RP Whitlock","year":"2012","unstructured":"Whitlock RP, Sun JC, Fremes SE, et al. Antithrombotic and thrombolytic therapy for valvular disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141:e576S\u2013600S.","journal-title":"Chest"},{"key":"1324_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11239-006-4969-y","volume":"21","author":"FM Caceres-Loriga","year":"2006","unstructured":"Caceres-Loriga FM, Perez-Lopez H, Morlans-Hernandez K, et al. Thrombolysis as first choice therapy in prosthetic heart valve thrombosis: a study of 68 patients. J Thromb Thrombolysis. 2006;21:185\u201390.","journal-title":"J Thromb Thrombolysis"},{"key":"1324_CR11","first-page":"101","volume":"46","author":"D Rajasekhar","year":"1994","unstructured":"Rajasekhar D, Balakrishnan KG, Venkitachalam CG, et al. Thrombolytic therapy for prosthetic cardiac valve thrombosis. Indian Heart J. 1994;46:101\u20135.","journal-title":"Indian Heart J"},{"key":"1324_CR12","first-page":"8","volume":"86","author":"R Roudaut","year":"1992","unstructured":"Roudaut R, Labbe T. Marie-Frangoise, et al. mechanical cardiac valve thrombosis is fibrinolysis justified? Circulation. 1992;86:8\u201315.","journal-title":"Circulation."},{"key":"1324_CR13","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/S0735-1097(02)02872-3","volume":"41","author":"R Roudaut","year":"2003","unstructured":"Roudaut R, Lafitte S, Roudaut MF, et al. Fibrinolysis of mechanical prosthetic valve thrombosis a single-center study of 127 cases. J Am Coll Cardiol. 2003;41:653\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"1324_CR14","first-page":"309","volume":"78","author":"E Reyes-Cerezo","year":"2008","unstructured":"Reyes-Cerezo E, Jerjes-Sanchez C, Archondo-Arce T, et al. Fibrinolytic therapy in left side prosthetic valve acute thrombosis.: in depth systematic review. Arch Cardiol Mex. 2008;78:309\u201317.","journal-title":"Arch Cardiol Mex"},{"key":"1324_CR15","first-page":"636","volume":"10","author":"M Lengyel","year":"2001","unstructured":"Lengyel M, Vandor L. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography. J Heart Valve Dis. 2001;10:636\u201349.","journal-title":"J Heart Valve Dis"},{"key":"1324_CR16","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.ihj.2015.08.019","volume":"67","author":"FM C\u00e1ceres-L\u00f3riga","year":"2015","unstructured":"C\u00e1ceres-L\u00f3riga FM, Morais H. Thrombotic obstruction in left-side prosthetic valves: role of thrombolytic therapy. Indian Heart J. 2015;67:S10\u20132.","journal-title":"Indian Heart J"},{"key":"1324_CR17","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","volume":"135","author":"RA Nishimura","year":"2017","unstructured":"Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA\/ACC focused update of the 2014 AHA\/ACC guideline for the Management of Patients with Valvular heart disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation. 2017;135:e1159\u201395.","journal-title":"Circulation."},{"key":"1324_CR18","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.ahj.2015.03.003","volume":"169","author":"M Kal\u00e7\u0131k","year":"2015","unstructured":"Kal\u00e7\u0131k M, G\u00fcrsoy MO, Yesin M, et al. Transesophageal echocardiography is an indispensable guide during thrombolytic therapy for prosthetic valve thrombosis. Am Heart J. 2015;169:e13\u20134.","journal-title":"Am Heart J"},{"key":"1324_CR19","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ihj.2018.09.008","volume":"70","author":"A Guner","year":"2018","unstructured":"Guner A, Kalkan S, \u00d6zkan M. Two and real-time three-dimensional transesophageal echocardiography guided thrombolytic therapy for prosthetic valve thrombosis is crucial. Indian Heart J. 2018;70:950\u20131.","journal-title":"Indian Heart J"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01324-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-020-01324-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-020-01324-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T01:53:43Z","timestamp":1633053223000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-020-01324-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1324"],"URL":"https:\/\/doi.org\/10.1186\/s13019-020-01324-7","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Medical Ethics Committee of Fujian Provincial Hospital approved this study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}